A randomized controlled study of wearable devices combined with Baduanjin in the management of movement in metabolic syndrome

Authors
Category Primary study
Registry of TrialsITMCTR
Year 2022
INTERVENTION: control group:no intervention;Treatment group:Wearable devices combined with Baduanjin;Treatment group:Wearable devices; CONDITION: Metabolic syndrome PRIMARY OUTCOME: HOMA‐IR; SECONDARY OUTCOME: BMI;Blood glucose;TCM symptom score;Exercise adherence;Blood pressure;EQ‐5D health inde Xscale;Body fat rate;Blood fat; INCLUSION CRITERIA: ?Age between 18 and 70 years old. ?Patients in the outpatient clinic and ward of the Department of Endocrinology of Guangdong Provincial Hospital of Traditional Chinese Medicine. ?Patients who meet the diagnosis of metabolic syndrome; and BMI = 24 kg/m2 . ?Those who signed the informed consent form.
Epistemonikos ID: 41def86d35e1e90eb1e51e922e33fa0dfe057aa8
First added on: Aug 26, 2024